Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 236 CNY -4.49% Market Closed
Market Cap: 142.4B CNY
Have any thoughts about
Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Wall Street analysts forecast Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 280.87 CNY with a low forecast of 176.75 CNY and a high forecast of 375.9 CNY.

Lowest
Price Target
176.75 CNY
25% Downside
Average
Price Target
280.87 CNY
19% Upside
Highest
Price Target
375.9 CNY
59% Upside
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors:
Price Targets
ROVI
Laboratorios Farmaceuticos ROVI SA
53% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
23% Upside
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
35% Upside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
61% Upside
4521
Kaken Pharmaceutical Co Ltd
18% Downside
CAMX
Camurus AB
25% Upside
ABBOTINDIA
Abbott India Ltd
12% Upside

Revenue
Forecast

Revenue Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 23%. The projected CAGR for the next 3 years is 13%.

23%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 3 years is 15%.

26%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 15%.

25%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's stock price target?
Price Target
280.87 CNY

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 280.87 CNY with a low forecast of 176.75 CNY and a high forecast of 375.9 CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 23%. The projected CAGR for the next 3 years is 13%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 3 years is 15%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 15%.

Back to Top